Nautilus Biotechnology, Inc.（NAUT）内部人交易：高管与董事近期交易
过去 18 个月，共有 11 位内部人为 Nautilus Biotechnology, Inc.（NAUT）报告了 20 笔 Form 4 交易（最近一笔 2026-06-04）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-04 | Andreessen Marc L | 10% 以上股东 | 卖出 | 4.6M | $10.8M |
| 2026-06-04 | HOROWITZ BENJAMIN A | 10% 以上股东 | 卖出 | 4.6M | $10.8M |
| 2026-06-04 | AH Bio Fund II, L.P. | 10% 以上股东 | 卖出 | 4.6M | $10.8M |
| 2026-06-04 | AH Equity Partners Bio II, L.L.C. | 10% 以上股东 | 卖出 | 4.6M | $10.8M |
| 2026-06-04 | Andreessen Horowitz LSV Fund II, L.P. | 10% 以上股东 | 卖出 | 4.6M | $10.8M |
| 2026-06-04 | AH Equity Partners LSV II, L.L.C. | 10% 以上股东 | 卖出 | 4.6M | $10.8M |
| 2026-06-04 | Andreessen Marc L | 10% 以上股东 | 卖出 | 384,026 | $902,461 |
| 2026-06-04 | HOROWITZ BENJAMIN A | 10% 以上股东 | 卖出 | 384,026 | $902,461 |
| 2026-06-04 | AH Bio Fund II, L.P. | 10% 以上股东 | 卖出 | 384,026 | $902,461 |
| 2026-06-04 | AH Equity Partners Bio II, L.L.C. | 10% 以上股东 | 卖出 | 384,026 | $902,461 |
| 2026-06-04 | Andreessen Horowitz LSV Fund II, L.P. | 10% 以上股东 | 卖出 | 384,026 | $902,461 |
| 2026-06-04 | AH Equity Partners LSV II, L.L.C. | 10% 以上股东 | 卖出 | 384,026 | $902,461 |
| 2026-03-04 | Patel Sujal M | CEO, President, and Secretary | 买入 | 25,000 | $65,250 |
| 2025-11-10 | Suzuki Kentaro | Chief Marketing Officer | 买入 | 4,000 | $5,960 |
| 2025-09-09 | Patel Sujal M | CEO, President, and Secretary | 买入 | 116,500 | $78,055 |
| 2025-09-09 | Patel Sujal M | CEO, President, and Secretary | 买入 | 83,500 | $56,780 |
| 2025-09-05 | Murphy Matthew B. | General Counsel | 买入 | 20,000 | $12,800 |
| 2025-06-02 | Mowry Anna | CFO and Treasurer | 买入 | 15,000 | $11,550 |
| 2025-05-12 | Mallick Parag | Chief Scientist | 买入 | 12,000 | $8,760 |
| 2025-05-12 | Mallick Parag | Chief Scientist | 买入 | 1,500 | $1,095 |
来源：SEC Form 4 申报文件 · 截至 2026-06-04